COVID-19 & Cancer

COVID-19 & Cancer

Early in 2020, we watched with growing alarm as early warnings of the virulence of SARS-CoV-2 started pouring in from Wuhan, and later, from Lombardy. At The Cancer Letter, we quickly decided to chart a course for intensive coverage of the pandemic as it reached our shores—oncologists are well-poised to take the lead in shaping research on COVID-19, and exposure mitigation strategies for high-risk patients. This coverage is collected here.
As screening declines amid COVID-19, at-home stool DNA test for CRC gets high adherence in Medicare population
COVID-19 & CancerFreeTrials & Tribulations

As screening declines amid COVID-19, at-home stool DNA test for CRC gets high adherence in Medicare population

In the midst of the heavy burden COVID-19 has placed on the health care system, cancer remains relentless. The already difficult journey for cancer patients has become more uncertain as the ways we provide and access healthcare have changed to accommodate measures that protect both health care providers and cancer patients from COVID-19.
Impact of COVID-19 on Georgia’s community providers: a snapshot from Georgia NCORP
COVID-19 & CancerFreeGuest Editorial

Impact of COVID-19 on Georgia’s community providers: a snapshot from Georgia NCORP

As we approach the middle of June, Georgia appears to have come to the other side of its COVID-19 curve. Available information from the Georgia Department of Health reveals Georgia has nearly 54,000 confirmed COVID-19 cases, with the heaviest concentration of cases in the metro Atlanta area (as a result of population size, not density).